121 results on '"Mateo‐Lozano, Silvia"'
Search Results
2. Supplementary Data from Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
3. Data from The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis
4. Supplementary Figure 4 from Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
5. Methods and Materials, Figure 4 Legend from Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
6. Supplementary Methods, Figure and Table Legends from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
7. Data from Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
8. Supplementary Table 1 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
9. Supplementary Figures 1-4 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
10. Supplementary Table 2 from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
11. Supplementary Figures 1-6, Tables 1-6 from The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis
12. Data from Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
13. KDM6 demethylases mediate EWSR1-FLI1-driven oncogenic transformation in Ewing Sarcoma
14. Brush border Myosin la has tumor suppressor activity in the intestine
15. AC-265347 Inhibits Neuroblastoma Tumor Growth by Induction of Differentiation without Causing Hypocalcemia
16. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax : Bcl-xL ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity
17. Rapamycin induces the fusion-type independent downregulation of the EWS/FLI-1 proteins and inhibits Ewing's sarcoma cell proliferation
18. Brush border myosin Ia inactivation in gastric but not endometrial tumors
19. Targeting EWS/FLI1 Driven Signaling Pathways as Therapy for Tumors of the Ewing’s Sarcoma Family
20. Caveolin-1 promotes resistance to chemotherapy-induced apoptosis in Ewingʼs sarcoma cells by modulating PKCα phosphorylation
21. Parathyroid hormone‐like hormone plays a dual role in neuroblastoma depending onPTH1R expression
22. Loss of the EPH receptor B6 contributes to colorectal cancer metastasis
23. Parathyroid hormone‐like hormone plays a dual role in neuroblastoma depending on PTH1R expression.
24. Caveolin-1 promotes Ewing sarcoma metastasis regulating MMP-9 expression through MAPK/ERK pathway
25. Regulation of Differentiation by Calcium-Sensing Receptor in Normal and Tumoral Developing Nervous System
26. Abstract A18: Epigenetic profiling uncovers the suppressive role of caveolae in Ewing sarcoma
27. Cinacalcet inhibits neuroblastoma tumor growth and upregulates cancer-testis antigens
28. Abstract 2058: RHOA inactivation enhances Wnt signaling and promotes colorectal cancer
29. Sarcoma de Ewing: nuevas aproximaciones terapéuticas y búsqueda de dianas biológicas del oncogén EWS/FLI-1
30. RHOA inactivation enhances Wnt signalling and promotes colorectal cancer
31. Caveolin-1 is down-regulated in alveolar rhabdomyosarcomas and negatively regulates tumor growth
32. Chapter 330 - Targeting EWS/FLI1 Driven Signaling Pathways as Therapy for Tumors of the Ewing’s Sarcoma Family
33. EphA2-Induced Angiogenesis in Ewing Sarcoma Cells Works through bFGF Production and Is Dependent on Caveolin-1
34. The dual inhibitory effect of thiostrepton on FoxM1 and EWS/FLI1 provides a novel therapeutic option for Ewing’s sarcoma
35. Abstract 3827: Caveolin-1 acts as a tumor suppressor promoting muscular differentiation in alveolar rhabdomyosarcomas.
36. Sarcoma de Ewing nuevas aproximaciones terapéuticas y búsqueda de dianas biológicas del oncogén EWS/FLI-1
37. Brush border myosin Ia inactivation in gastric but not endometrial tumors
38. Abstract 1429: Forkhead box M1 (FoxM1) is a direct transcriptional target of EWS/FLI1 and a regulator of Ewing's sarcoma cell morphology, adhesiveness and tumorigenicity
39. Brush border Myosin Ia has tumor suppressor activity in the intestine
40. Targeted Therapies in Sarcomas: Challenging the Challenge
41. Caveolin-1 in sarcomas: friend or foe?
42. Caveolin-1 Modulates the Ability of Ewing's Sarcoma to Metastasize
43. Aprataxin Tumor Levels Predict Response of Colorectal Cancer Patients to Irinotecan-based Treatment
44. Abstract 5756: The receptor tyrosine kinase EPHB4 has tumor suppressor activities in intestinal tumorigenesis
45. Abstract 3405: Caveolin-1 modulates the metastatic ability of Ewing's sarcoma
46. The Receptor Tyrosine Kinase EPHB4 Has Tumor Suppressor Activities in Intestinal Tumorigenesis
47. Pyrazolo[1,5-a]-1,3,5-triazine as a Purine Bioisostere: Access to Potent Cyclin-Dependent Kinase Inhibitor (R)-Roscovitine Analogue
48. Meriolins, a New Class of Cell Death–Inducing Kinase Inhibitors with Enhanced Selectivity for Cyclin-Dependent Kinases
49. Combined Transcriptional and Translational Targeting of EWS/FLI-1 in Ewing's Sarcoma
50. Caveolin-1 (CAV1) Is a Target of EWS/FLI-1 and a Key Determinant of the Oncogenic Phenotype and Tumorigenicity of Ewing's Sarcoma Cells
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.